Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CHD9(Gene name) > Human
  • Add your favorite
  • CHD9 (Gene name),
  • Chromodomain-helicase-DNA-binding protein 9 (Protein name ),  CHD9_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    CHD9(AD-013;x0008;KIAA0308;KISH2;PRIC320);
    Protein name:
    Chromodomain-helicase-DNA-binding protein 9(CHD-9);
    Alternative:
    Chromatin-related mesenchymal modulator(CReMM);ATP-dependent helicase CHD9;Kismet homolog 2;Chromatin-remodeling factor CHROM1;Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;PPAR-alpha-interacting complex protein 320 kDa;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with PPARA. Probably interacts with ESR1 and NR1I3.
    Function:
    Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis.
    Subcellular Location:
    Cytoplasm Nucleus
    Protein Attributes:
    Sequence length:
    2897
    Sequence:
    50:
    MTDPMMDFFD | DANLFGETLE | GLSDDAFVQP | GPVSLVDELN | LGAEFEPLHI | 
    100:
    DSLNHVQGTP | THQKMTDFEQ | LNQFDSIKFH | HVNQSFGSPA | EHVLSPHSQF | 
    150:
    NCSPIHPQNQ | PNGLFPDVSD | GSPMWGHQTA | TTISNQNGSP | FHQQGHSHSM | 
    200:
    HQNKSFVAHH | DFALFQANEQ | QTQCTSLRSQ | QNRNNLNPGQ | NSLSQSKNFM | 
    250:
    NVSGPHRVNV | NHPPQMTNAS | NSQQSISMQQ | FSQTSNPSAH | FHKCSSHQEG | 
    300:
    NFNGPSPNMT | SCSVSNSQQF | SSHYSFSSNH | ISPNSLLQSS | AVLASNHTNQ | 
    350:
    TLSDFTGSNS | FSPHRGIKQE | STQHILNPNT | SLNSNNFQIL | HSSHPQGNYS | 
    400:
    NSKLSPVHMN | FPDPVDSGTQ | MGHFNDHVET | NGFSSLEENL | LHQVESQTEP | 
    450:
    FTGLDPEDLL | QEGLLPHFDE | STFGQDNSSH | ILDHDLDRQF | TSHLVTRPSD | 
    500:
    MAQTQLQSQA | RSWHSSFSNH | QHLHDRNHLC | LQRQPPSSKK | SDGSGTYTKL | 
    550:
    QNTQVRVMSE | KKQRKKVESE | SKQEKANRII | SEAIAKAKER | GERNIPRVMS | 
    600:
    PENFPTASVE | GKEEKKGRRM | KSKPKDKDSK | KTKTCSKLKE | KTKIGKLIIT | 
    650:
    LGKKQKRKNE | SSDEISDAEQ | MPQHTLKDQD | SQKRRSNRQI | KRKKYAEDIE | 
    700:
    GKQSEEEVKG | SMKIKKNSAP | LPGEQPLQLF | VENPSEEDAA | IVDKILSSRT | 
    750:
    VKKEISPGVM | IDTEEFFVKY | KNYSYLHCEW | ATEEQLLKDK | RIQQKIKRFK | 
    800:
    LRQAQRAHFF | ADMEEEPFNP | DYVEVDRVLE | VSFCEDKDTG | EPVIYYLVKW | 
    850:
    CSLPYEDSTW | ELKEDVDLAK | IEEFEQLQAS | RPDTRRLDRP | PSNIWKKIDQ | 
    900:
    SRDYKNGNQL | REYQLEGLNW | LLFNWYNRRN | CILADEMGLG | KTIQSITFLY | 
    950:
    EILLTGIRGP | FLIIAPLSTI | ANWEREFRTW | TDINVVVYHG | SLISRQMIQQ | 
    1000:
    YEMYFRDSQG | RIIRGAYRFQ | AIITTFEMIL | GGCGELNAIE | WRCVIIDEAH | 
    1050:
    RLKNKNCKLL | EGLKLMNLEH | KVLLTGTPLQ | NTVEELFSLL | HFLEPLRFPS | 
    1100:
    ESTFMQEFGD | LKTEEQVQKL | QAILKPMMLR | RLKEDVEKKL | APKEETIIEV | 
    1150:
    ELTNIQKKYY | RAILEKNFSF | LSKGAGQTNV | PNLVNTMMEL | RKCCNHPYLI | 
    1200:
    KGAEEKILGE | FRDTYNPAAS | DFHLQAMIQS | AGKLVLIDKL | LPKMKAGGHK | 
    1250:
    VLIFSQMVRC | LDILEDYLIH | KRYLYERIDG | RVRGNLRQAA | IDRFSKPDSD | 
    1300:
    RFVFLLCTRA | GGLGINLTAA | DTCIIFDSDW | NPQNDLQAQA | RCHRIGQNKA | 
    1350:
    VKVYRLVTRN | SYEREMFDRA | SLKLGLDKAV | LQSMSGRESN | VGGIQQLSKK | 
    1400:
    EIEDLLRRGA | YGAIMEEEDE | GSKFCEEDID | QILLRRTKTI | TIESEGRGST | 
    1450:
    FAKASFVASG | NRTDISLDDP | NFWQKWAKKA | EIDIEAISGR | NSLVIDTPRI | 
    1500:
    RKQTRPFSAT | KDELAELSEA | ESEGDEKPKL | RRPCDRSNGY | GRTECFRVEK | 
    1550:
    NLLVYGWGRW | REILSHGRFK | RQLNEHDVEI | ICRALLAYCL | VHYRGDEKIK | 
    1600:
    GFIWDLITPT | EDGQTRELQN | HLGLSAPVPR | GRKGKKVKTQ | TSSFDIQKAE | 
    1650:
    WLRKYNPEQL | LQDEGYKKHI | KHHCNKVLLR | VRMLYYLKQE | VIGNECQKVF | 
    1700:
    DGVDASDIDV | WVPEPDHSEV | PAEWWDFDAD | KSLLIGVFKH | GYEKYNTIRA | 
    1750:
    DPALCFLERV | GKPDEKAVAA | EQRANDYMDG | DVEDPEYKPA | PAIFKDDIED | 
    1800:
    DVSSPGDLVI | ADGDGQLMEG | DKVYWPTQSA | LTTRLRRLIT | AYQRTNKNRQ | 
    1850:
    IQQIQPTFSV | PTSVMQPIYE | EATLNPKMAA | KIERQQRWTR | REEADFYRVV | 
    1900:
    STFGVVFDPD | RGQFDWTKFR | AMARLHKKTD | DSLEKYLYAF | MSMCRRVCRL | 
    1950:
    PSKEELVDPN | IFIQPITEER | ASRTLYRIEL | LRKVREQALR | HPQLFERLKL | 
    2000:
    CHPNPDLPVW | WECGPHDRDL | LIGAAKHGVS | RTDYHILRDP | ELSFMAAQRN | 
    2050:
    YSQSKMAHSR | TSTPLLQQYQ | VALSASPLTS | LPRLLDAKGI | ILEEMKVKSE | 
    2100:
    NLKEEPQSSE | EESMSSVETR | TLIKSEPVSP | KNGVLPQATG | DQKSGGKCET | 
    2150:
    DRRMVAARTE | PLTPNPASKK | PRVHKRGSES | SSDSDSDSER | SSCSSRSSSS | 
    2200:
    SSSSSCSHSR | SGSSSSSSSS | CSSASSSSSS | STSSSSSSSS | SSSEESDSDE | 
    2250:
    EEAQKRESTT | HMKAYDEESV | ASLSTTQDET | QDSFQMNNGT | PESAYILQGG | 
    2300:
    YMLAASYWPK | DRVMINRLDS | ICQTVLKGKW | PSARRSYDAN | TVASFYTTKL | 
    2350:
    LDSPGAATEY | SDPSVPTPPG | AGVKEEHDQS | TQMSKVKKHV | REKEFTVKIK | 
    2400:
    DEGGLKLTFQ | KQGLAQKRPF | DGEDGALGQQ | QYLTRLRELQ | SASETSLVNF | 
    2450:
    PKSIPVSGTS | IQPTLGANGV | ILDNQPIVKK | RRGRRKNVEG | VDIFFFNRNK | 
    2500:
    PPNHVSLGLT | SSQISTGINP | ALSYTQPQGI | PDTESPVPVI | NLKDGTRLAG | 
    2550:
    DDAPKRKDLE | KWLKEHPGYV | EDLGAFIPRM | QLHEGRPKQK | RHRCRNPNKL | 
    2600:
    DVNSLTGEER | VQLINRRNAR | KVGGAFAPPL | KDLCRFLKEN | SEYGVAPEWG | 
    2650:
    DVVKQSGFLP | ESMYERILTG | PVVREEVSRR | GRRPKSGIAK | ATAAAAAASA | 
    2700:
    TSVSGNPLLA | NGLLPGVDLT | TLQALQQNLQ | NLQSLQVTAG | LMGMPTGLPS | 
    2750:
    GGEAKNMAAM | FPMLLSGMAG | LPNLLGMGGL | LTKPTESGTE | DKKGSDSKES | 
    2800:
    EGKTERTESQ | SSENGGENSV | SSSPSTSSTA | ALNTAAAANP | LALNPLLLSN | 
    2850:
    ILYPGMLLTP | GLNLHIPTLS | QSNTFDVQNK | NSDLGSSKSV | EVKEEDSRIK | 
    2897:
    DQEDKGGTEP | SPLNENSTDE | GSEKADASSG | SDSTSSSSED | SDSSNED
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    String:
    UniGene:
    Pfam:
    KEGG:
    SMR:
    Uniprot:
     
    FOR
    ELISA Kit for Human CHD-9
    ELISA Kit for Human CHD-9
    CLIA Kit for Human CHD-9
    CLIA Kit for Human CHD-9
    Polyclonal Antibody for Human CHD-9
    Polyclonal Antibody for Human CHD-9
    Monoclonal Antibody for Human CHD-9
    Monoclonal Antibody for Human CHD-9
    Protein for Human CHD-9
    Protein for Human CHD-9

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Characterization and functional analysis of CReMM, a novel chromodomain helicase DNA-binding protein."
      Shur I. , Benayahu D.
      J. Mol. Biol.352:646-655(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);FUNCTION;SUBCELLULAR LOCATION;TISSUE SPECIFICITY;PHOSPHORYLATION;VARIANT GLU-2312
      tissue: Bone marrow stroma.
    2. 2.
      "PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex."
      Surapureddi S. , Viswakarma N. , Yu S. , Guo D. , Rao M.S. , Reddy J.K.
      Biochem. Biophys. Res. Commun.343:535-543(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2);FUNCTION;TISSUE SPECIFICITY;VARIANT GLU-2312;INTERACTION WITH PPARA; ESR1 AND NR1I3
    3. 3.
      "Cloning of the mammalian orthologs of Drosophila melanogaster gene KISMET."
      Colin C. , Dahia P.L.M. , Stiles C.D. , Sogayar M.C.
      Submitted (2004-06) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)
      tissue: Pharynx carcinoma.
    4. 4.
      "The sequence and analysis of duplication-rich human chromosome 16."
      Martin J. , Han C. , Gordon L.A. , Terry A. , Prabhakar S. , She X. , Xie G. , Hellsten U. , Chan Y.M. , Altherr M. , Couronne O. , Aerts A. , Bajorek E. , Black S. , Blumer H. , Branscomb E. , Brown N.C. , Bruno W.J. , more...
      Nature432:988-994(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    5. 5.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
    6. 6.
      "Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro."
      Nagase T. , Ishikawa K. , Nakajima D. , Ohira M. , Seki N. , Miyajima N. , Tanaka A. , Kotani H. , Nomura N. , Ohara O.
      DNA Res.4:141-150(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 124-2897 (ISOFORM 3);VARIANT GLU-2312
      tissue: Brain.
    7. 7.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 485-639
      tissue: Adrenal gland.
    8. 8.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 886-1616
    9. 9.
      "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
      Olsen J.V. , Blagoev B. , Gnad F. , Macek B. , Kumar C. , Mortensen P. , Mann M.
      Cell127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1468 AND SER-1472;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    10. 10.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550; SER-611 AND SER-2026;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    11. 11.
      "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
      Gauci S. , Helbig A.O. , Slijper M. , Krijgsveld J. , Heck A.J. , Mohammed S.
      Anal. Chem.81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    12. 12.
      "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
      Mayya V. , Lundgren D.H. , Hwang S.-I. , Rezaul K. , Wu L. , Eng J.K. , Rodionov V. , Han D.K.
      Sci. Signal.2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550; SER-2058 AND SER-2059;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    13. 13.
      "Lysine acetylation targets protein complexes and co-regulates major cellular functions."
      Choudhary C. , Kumar C. , Gnad F. , Nielsen M.L. , Rehman M. , Walther T.C. , Olsen J.V. , Mann M.
      Science325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-499;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    14. 14.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550; SER-1468 AND SER-1472;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter